The effects of temocapril, a new angiotensin converting enzyme inhibitor, on the quality of life in hypertensive patients

Add time:08/09/2019    Source:sciencedirect.com

A multicenter open study was performed to evaluate the hypotensive efficacy, safety, usefulness, and influence on quality of life of temocapril administered alone for 6 months. Sixty-two patients with essential hypertension, including 33 patients age 65 or older, were enrolled in the study. Of these 62 patients, 4 withdrew from treatment because of side effects, 1 because of insufficient hypotensive effects, and 2 for personal reasons. Temocapril, given at a dosage of 1 to 8 mg/day, produced a dose-dependent reduction in blood pressure without changing the pulse rate. Sufficient blood pressure reduction was achieved at the end of the study in 87.7% of the patients. Quality of life, as assessed by the attending physicians, was rated as “improved” in 67.9% of the patients. Significant improvements in mean quality-of-life scores were noted in “general symptoms,” “work performance and satisfaction,” “physical symptoms and general well-being,” “sleep,” “emotional state,” “self-control,” and “vitality.” Side effects occurred in 7 (11.5%) patients, including cough in (4.9%) 3. In the patients age 65 and older, significant improvement was obtained in “general symptoms,” “work performance and satisfaction,” “physical symptoms and general well-being,” and “emotional state.” These results indicate that long-term antihypertensive therapy with temocapril alone is useful for treating essential hypertension, even in elderly patients. In addition, this therapy has favorable effects on the patients' quality of life.

We also recommend Trading Suppliers and Manufacturers of Temocapril hydrochloride (cas 110221-44-8). Pls Click Website Link as below: cas 110221-44-8 suppliers

Prev:Evaluation of Transport Mechanism of Prodrugs and Parent Drugs Formed by Intracellular Metabolism in Caco-2 Cells with Modified Carboxylesterase Activity: Temocapril as a Model Case
Next:Biliary excretion of taurolithocholate-sulfate and Temocaprilat (cas 110221-53-9) in cholestatic rats induced by bile duct-ligation and ethinylestradiol)